{"id":"normosol-r-inj","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypervolemia (fluid overload)"},{"rate":null,"effect":"Hyponatremia"},{"rate":null,"effect":"Hyperkalemia"},{"rate":null,"effect":"Phlebitis at infusion site"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Normosol-R is a sterile, nonpyrogenic crystalloid solution containing sodium, potassium, magnesium, chloride, acetate, and gluconate in concentrations designed to approximate plasma electrolyte composition. It is used for fluid and electrolyte replacement in patients with dehydration, hypovolemia, or electrolyte imbalances, helping to restore intravascular volume and maintain normal osmotic balance without the hyperchloremic acidosis associated with normal saline.","oneSentence":"Normosol-R is a balanced crystalloid intravenous fluid that replaces electrolytes and fluid volume to maintain physiological homeostasis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:23:25.142Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Fluid and electrolyte replacement in dehydration and hypovolemia"},{"name":"Perioperative fluid management"},{"name":"Maintenance of electrolyte balance in hospitalized patients"}]},"trialDetails":[{"nctId":"NCT05832047","phase":"PHASE4","title":"Aggressive Hydration With Lactated Ringer's Solution Versus Plasma Solution for the Prevention of Post ERCP Pancreatitis","status":"COMPLETED","sponsor":"Do Hyun Park","startDate":"2023-06-19","conditions":"Pancreatic Disease","enrollment":844},{"nctId":"NCT03054922","phase":"PHASE3","title":"Impact of Intraoperative Fluid Management on Electrolyte and Acid-base Variables","status":"COMPLETED","sponsor":"Nationwide Children's Hospital","startDate":"2017-02-23","conditions":"Anesthesia","enrollment":59}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Normosol-R Inj","genericName":"Normosol-R Inj","companyName":"Nationwide Children's Hospital","companyId":"nationwide-children-s-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Normosol-R is a balanced crystalloid intravenous fluid that replaces electrolytes and fluid volume to maintain physiological homeostasis. Used for Fluid and electrolyte replacement in dehydration and hypovolemia, Perioperative fluid management, Maintenance of electrolyte balance in hospitalized patients.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}